
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **FABP7 (Fatty Acid Binding Protein 7):** Involved in fatty acid metabolism, often associated with neural tissues and certain cancer types.<br>- **MT1H, MT1G (Metallothioneins):** Involved in metal ion binding and detoxification, often upregulated in response to stress and in various cancers.<br>- **MYEOV (Myeloma Overexpressed):** Associated with cell proliferation and often overexpressed in cancers.<br>- **RAMP2 (Receptor Activity Modifying Protein 2):** Involved in receptor activity modulation, particularly in vascular and endothelial cells.<br>- **NDRG2 (N-Myc Downstream Regulated 2):** Associated with cell differentiation and stress response, often acting as a tumor suppressor.<br>- **MARCKSL1 (MARCKS Like 1):** Involved in cell motility and cytoskeletal organization.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT15 (Keratin 15):** A marker for epithelial cells, particularly basal cells in the skin and mammary gland.<br>- **KRT19 (Keratin 19):** Commonly expressed in epithelial cells, often used as a marker for breast epithelial cells and certain carcinomas.<br>- **SIX3 (Sine Oculis Homeobox Homolog 3):** A transcription factor involved in development, with expression in certain progenitor cells.<br>- **SOX4 (SRY-Box Transcription Factor 4):** A transcription factor involved in development and differentiation, often implicated in cancer progression.<br><br>### Step 3: Cross-reference Known Databases<br>Using scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer, we can cross-reference these markers:<br>- **KRT15 and KRT19** are well-documented markers for epithelial cells, particularly in the context of breast tissue.<br>- **FABP7** is often associated with neural tissues but can be expressed in certain cancerous tissues, including breast cancer.<br>- **SOX4** is frequently implicated in breast cancer progression and metastasis.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of **KRT15** and **KRT19**, the most probable general cell type is **epithelial cells**. These markers are indicative of cells that form the lining of the breast ducts and are commonly involved in breast cancer.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Basal Epithelial Cells:** Characterized by the expression of **KRT15**, these cells are part of the basal layer of the mammary epithelium.<br>2. **Luminal Epithelial Cells:** Characterized by the expression of **KRT19**, these cells line the ducts and lobules of the breast.<br>3. **Cancer Stem-like Cells:** Given the expression of **SOX4** and **FABP7**, which are associated with stemness and cancer progression, a subset of these cells may exhibit stem-like properties.<br><br>**Most Likely Subtype:** Based on the expression of **KRT15** and **KRT19**, the most likely subtype is **Basal Epithelial Cells**. These cells are often implicated in basal-like breast cancer, a subtype of triple-negative breast cancer.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is primarily composed of epithelial cells, with a strong indication towards basal epithelial cells. The presence of markers such as **KRT15** and **KRT19** supports this annotation, while the expression of **SOX4** and **FABP7** suggests potential cancer stem-like properties within the cluster. This aligns with the characteristics of basal-like breast cancer, a subtype known for its aggressive nature and lack of hormone receptor expression.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers used in the annotation (e.g., FABP7, MT1H, MT1G, MYEOV, RAMP2, NDRG2, MARCKSL1, KRT15, KRT19, SIX3, SOX4) are present in the provided marker list.<br>   - The markers KRT15 and KRT19 are well-known markers for epithelial cells, particularly in breast tissue, which supports the annotation of epithelial cells.<br>   - SOX4 and FABP7 are associated with cancer progression and stem-like properties, which aligns with the identification of potential cancer stem-like cells.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation considers the possibility of mixed cell types by identifying basal epithelial cells, luminal epithelial cells, and cancer stem-like cells. This is supported by the presence of multiple high-ranking markers that are indicative of these subtypes.<br>   - The analysis appropriately flags the potential for cancer stem-like properties within the cluster, which is a reasonable consideration given the expression of SOX4 and FABP7.<br><br>Overall, the annotation is well-supported by the marker list and the context of breast cancer tissue, and it provides a comprehensive analysis of the potential cell types present in the cluster.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Basal Epithelial Cells</li><li>Luminal Epithelial Cells</li><li>Cancer Stem-like Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a well-structured approach to identifying cell types from a single-cell dataset derived from breast cancer tissue. The analysis effectively utilizes a combination of functional and cell type markers to arrive at a comprehensive annotation. Here are the key points of evaluation:<br><br>1. **Correctness of Annotations:**<br>   - The identification of epithelial cells as the main cell type is scientifically accurate, given the presence of markers such as KRT15 and KRT19, which are well-established markers for epithelial cells in breast tissue.<br>   - The consideration of basal epithelial cells as the most likely subtype is appropriate, as KRT15 is a known marker for basal cells in the mammary gland.<br><br>2. **Balanced Consideration of Multiple Markers:**<br>   - The analysis does a commendable job of balancing the use of different markers. It considers both functional markers (e.g., FABP7, MT1H, MYEOV) and cell type markers (e.g., KRT15, KRT19, SOX4) to provide a nuanced view of the cell populations.<br>   - The inclusion of markers like SOX4 and FABP7 to suggest the presence of cancer stem-like cells adds depth to the analysis, acknowledging the complexity of cancer cell populations.<br><br>3. **Ability to Capture the General Picture:**<br>   - The annotation captures the general picture of the cell populations by identifying potential subtypes within the epithelial cells, such as basal and luminal epithelial cells, as well as cancer stem-like cells.<br>   - The analysis appropriately considers the context of breast cancer, which often involves heterogeneous cell populations, including stem-like cells.<br><br>4. **Consideration of Marker Rank:**<br>   - While the analysis does not explicitly discuss the rank of markers, it effectively prioritizes key markers like KRT15 and KRT19, which are crucial for identifying epithelial cells in breast tissue.<br><br>Overall, the annotation is well-supported by the marker list and provides a comprehensive view of the cell types present in the dataset. There are no obvious misclassifications or oversights, and the analysis is consistent with current scientific understanding of breast cancer cell populations.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    